| Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis J Quek, KE Chan, ZY Wong, C Tan, B Tan, WH Lim, DJH Tan, ASP Tang, ... The lancet Gastroenterology & hepatology 8 (1), 20-30, 2023 | 158 | 2023 |
| The global burden of metabolic disease: Data from 2000 to 2019 NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin, WH Lim, ... Cell Metabolism 35 (3), 414-428. e3, 2023 | 153 | 2023 |
| Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta … DJH Tan, CH Ng, SY Lin, XH Pan, P Tay, WH Lim, M Teng, N Syn, G Lim, ... The Lancet Oncology 23 (4), 521-530, 2022 | 152 | 2022 |
| An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD GEH Lim, A Tang, CH Ng, YH Chin, WH Lim, DJH Tan, JN Yong, J Xiao, ... Clinical Gastroenterology and Hepatology 21 (3), 619-629. e7, 2023 | 142 | 2023 |
| A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease JZK Toh, XH Pan, PWL Tay, CH Ng, JN Yong, J Xiao, JH Koh, EY Tan, ... Clinical Gastroenterology and Hepatology 20 (11), 2462-2473. e10, 2022 | 81 | 2022 |
| Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 individuals ASP Tang, KE Chan, J Quek, J Xiao, P Tay, M Teng, KS Lee, SY Lin, ... Clinical and Molecular Hepatology 28 (3), 483, 2022 | 57 | 2022 |
| Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD-a systematic review and meta-analysis A Tang, CH Ng, PH Phang, KE Chan, YH Chin, CE Fu, RW Zeng, J Xiao, ... Clinical Gastroenterology and Hepatology 21 (7), 1750-1760. e12, 2023 | 56 | 2023 |
| Is fatty liver associated with depression? A meta-analysis and systematic review on the prevalence, risk factors, and outcomes of depression and non-alcoholic fatty liver disease J Xiao, LKE Lim, CH Ng, DJH Tan, WH Lim, CSH Ho, EXX Tan, AJ Sanyal, ... Frontiers in medicine 8, 691696, 2021 | 55 | 2021 |
| Placebo effect on progression and regression in NASH: evidence from a meta‐analysis CH Ng, J Xiao, WH Lim, YH Chin, JN Yong, DJH Tan, P Tay, N Syn, R Foo, ... Hepatology 75 (6), 1647-1661, 2022 | 43 | 2022 |
| Outcomes of nonalcoholic steatohepatitis after liver transplantation: an updated meta-analysis and systematic review JN Yong, WH Lim, CH Ng, DJH Tan, J Xiao, PWL Tay, SY Lin, N Syn, ... Clinical Gastroenterology and Hepatology 21 (1), 45-54. e6, 2023 | 37 | 2023 |
| UNOS down-staging criteria for liver transplantation of hepatocellular carcinoma: systematic review and meta-analysis of 25 studies DJH Tan, WH Lim, JN Yong, CH Ng, MD Muthiah, EX Tan, J Xiao, SY Lim, ... Clinical Gastroenterology and Hepatology 21 (6), 1475-1484, 2023 | 31 | 2023 |
| Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis JN Yong, CH Ng, CWM Lee, YY Chan, ASP Tang, M Teng, DJH Tan, ... Hepatology International 16 (2), 269-281, 2022 | 30 | 2022 |
| An epidemiological meta-analysis on the worldwide prevalence, resistance, and outcomes of spontaneous bacterial peritonitis in cirrhosis PWL Tay, J Xiao, DJH Tan, C Ng, YN Lye, WH Lim, VXY Teo, RRY Heng, ... Frontiers in Medicine 8, 693652, 2021 | 29 | 2021 |
| Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality CH Ng, ZY Wong, NWS Chew, KE Chan, J Xiao, N Sayed, WH Lim, ... Frontiers in Cardiovascular Medicine 9, 942753, 2022 | 26 | 2022 |
| Meta‐analysis: chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin RW Zeng, JN Yong, DJH Tan, CE Fu, WH Lim, J Xiao, KE Chan, C Tan, ... Alimentary pharmacology & therapeutics 57 (6), 600-609, 2023 | 24 | 2023 |
| Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis M Muthiah, CH Ng, KE Chan, CE Fu, WH Lim, DJH Tan, B Nah, G Kong, ... Annals of Hepatology 28 (1), 100762, 2023 | 24 | 2023 |
| A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis CH Ng, DJH Tan, KRY Nistala, N Syn, J Xiao, EXX Tan, FZ Woo, ... Hepatology International 15, 1196-1206, 2021 | 23 | 2021 |
| A meta‐analysis and systematic review on the global prevalence, risk factors, and outcomes of coronary artery disease in liver transplantation recipients J Xiao, JN Yong, CH Ng, N Syn, WH Lim, DJH Tan, EY Tan, D Huang, ... Liver Transplantation 28 (4), 689-699, 2022 | 21 | 2022 |
| Meta‐analysis: analysis of mechanistic pathways in the treatment of non‐alcoholic steatohepatitis. Evidence from a Bayesian network meta‐analysis CH Ng, MD Muthiah, J Xiao, YH Chin, G Lim, WH Lim, P Tay, DJH Tan, ... Alimentary Pharmacology & Therapeutics 55 (9), 1076-1087, 2022 | 18 | 2022 |
| Hepatic, extra-hepatic outcomes and causes of mortality in NAFLD–an umbrella overview of systematic review of meta-analysis J Xiao, CH Ng, KE Chan, C Fu, P Tay, JN Yong, WH Lim, DJH Tan, N Syn, ... Journal of Clinical and Experimental Hepatology 13 (4), 656-665, 2023 | 13 | 2023 |
